CLINICAL_TRIALS
trial_result
· 2017-11-17
Clinical Trial Update: Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET) [Phase 2]
Summary
Phase 2 dose-finding trial of GSK2248761 in antiretroviral therapy-naive HIV patients was terminated; results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 2 | Status: TERMINATED | Results posted: 2017-11-17